Davunetide vs hGHRH(1-37)OH

Head-to-head comparison of Davunetide (Activity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)) and hGHRH(1-37)OH (Human growth hormone-releasing factor (1-37) hydroxyl) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyDavunetidehGHRH(1-37)OH
CategoryCognitive EnhancementGrowth Hormone
Full NameActivity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)Human growth hormone-releasing factor (1-37) hydroxyl
Molecular Weight796.9 DaN/A
Half-Lifeshort; minutes to low hours5-20 minutes
Amino Acids837
Typical Dose1-10 mg/day research range1-2 mcg/kg
RouteIntranasalSubcutaneous/IV
Purity≥98%≥98%
Studies Count4060
Research StatusClinical/Pre-clinicalClinical Research

Davunetide Benefits

  • neuroprotection
  • microtubule support
  • attention support
  • memory preservation

hGHRH(1-37)OH Benefits

  • GH release studies
  • minimal-sequence mapping
  • receptor pharmacology
  • peptide stability research

Davunetide Dosing

intranasal research dosing|1-10 mg per dose in trials/preclinical work|once or twice daily

hGHRH(1-37)OH Dosing

1-2 mcg/kg SC or IV bolus|acute stimulation with serial GH assays|short-course research administration with biomarker monitoring

Davunetide Side Effects

  • nasal irritation
  • headache
  • limited efficacy in late-stage trials

hGHRH(1-37)OH Side Effects

  • flushing
  • headache
  • transient fatigue

Research Overview

Davunetide

Preclinical work showed davunetide can protect neurons, preserve synaptic structure, and improve performance in memory tasks. Human trials largely focused on neurodegenerative disease outcomes rather than stand-alone nootropic use, but the literature supports CNS activity.

hGHRH(1-37)OH

Human GHRF(1-37)OH has appeared in studies examining how loss of C-terminal residues affects biological activity at the GHRH receptor. It is often used alongside other fragments to define structure-activity relationships within the GHRH family.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Davunetide stacks with:

gpenoopeptdesmopressin

hGHRH(1-37)OH stacks with:

L-arginineL-lysineglycine
octapeptideADNPneuroprotectionghrhfragmentstructure-activityendocrinology